Apellis Pharmaceuticals
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
- Location
- —
- Roles tracked
- 0
- In pipeline
- 0
- Tracking since
- —
At a glance
You're tracking 0 roles at Apellis Pharmaceuticals. Track a role to start building momentum here.
Company intel
From the job board · LinkedIn data via posting sync- Industry
- Biotechnology Research
- Company size
- 561 people
- Headquarters
- Waltham, MA +2 more
- Founded
- 2008
- Type
- Public Company
- Total funding
- $919.6M
Apellis is now part of Biogen. Please follow along there for the latest news. In the coming weeks, this page will no longer be updated or monitored.
Targeted C3 Therapies
Complement System
Hematology
Ophthalmology
Nephrology
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Geographic Atrophy (GA)
C3 Glomerulopathy (C3G)
Gene Therapy
and Neurology
